News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-16 11:13:41 pm Poseida: April 2024 Data Could Shed Light On Differentiated CAR-T Advancement SeekingAlpha
2024-03-13 1:5:0 pm Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma PR Newswire
2024-03-10 6:55:5 am US$14.00 - That's What Analysts Think Poseida Therapeutics, Inc. (NASDAQ:PSTX) Is Worth After These Results Simply Wall St.
2024-03-09 5:21:49 am Poseida Therapeutics Full Year 2023 Earnings: Beats Expectations Simply Wall St.
2024-03-07 7:45:10 pm Poseida Therapeutics Inc (PSTX) Reports Fourth Quarter and Full Year 2023 Financial Results GuruFocus.com
2024-03-07 3:55:3 pm Poseida Therapeutics, Inc. (PSTX) Reports Q4 Loss, Tops Revenue Estimates Zacks
2024-03-07 1:5:0 pm Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023 PR Newswire
2024-03-04 1:5:0 pm Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
2024-02-27 2:45:32 am Institutional investors own a significant stake of 41% in Poseida Therapeutics, Inc. (NASDAQ:PSTX) Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information